Core Laboratories (CLB) PT Lowered to $77 at RBC Capital
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $12.45 --0%
Rating Summary:
9 Buy, 13 Hold, 7 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 12
Rating Summary:
9 Buy, 13 Hold, 7 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 12
Join SI Premium – FREE
RBC Capital analyst Kurt Hallead lowered the price target on Core Laboratories (NYSE: CLB) to $77.00 (from $95.00) while maintaining an Outperform rating.
- Reducing Estimates to Reflect US E&P Spending Stall
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Zscaler (ZS) PT Raised to $200 at TD Cowen
- Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst PT ChangeRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
